Arrayjet Introduces New Next-Generation Microarray Printers
These printers are for a wide range of microarray and microfluidics applications for pharmaceutical, diagnostic, and life science workflows.
These printers are for a wide range of microarray and microfluidics applications for pharmaceutical, diagnostic, and life science workflows.
Validation experiments were performed to assess the technical and clinical performance equivalence of the MammaPrint and Blueprint next-generation sequencing tests compared with the diagnostic microarray test.
SuperGold and SuperSilver substrates are designed to bring quick, easy implementation and affordability to gold-surface and silver-surface based assays.
Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
Read MoreLaboratory Corp of America Holdings, Burlington, NC, is offering a high-density microarray, Affymetrix-based technology (Whole-Genome Sampling Analysis).
Read More